Possible Activation of the Immune System by Chronic Peripheral Nesfatin-1 Application at the Acute Phase of Ischemia/Reperfusion Injury

Erciyes Medical Journal - Turkey
doi 10.5152/etd.2015.0023
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Kare Publishing

Related search

Molecular Characterization of the Transition From Acute to Chronic Kidney Injury Following Ischemia/Reperfusion

JCI insight
Medicine
2017English

Renal Ischemia-Reperfusion Injury Amplifies the Humoral Immune Response

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2013English

The Application Progress of MicroRNA in Cerebral Ischemia-Reperfusion Injury

DEStech Transactions on Biology and Health
2018English

Berberine Attenuates Myocardial Ischemia Reperfusion Injury by Suppressing the Activation of PI3K/AKT Signaling

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2016English

The Application and Analytical Pathway of Dexmedetomidine in Ischemia/Reperfusion Injury

Journal of Analytical Methods in Chemistry
InstrumentationComputer Science ApplicationsAnalytical ChemistryChemical Engineering
2019English

Sphingosine Kinase 1 Protects Against Renal Ischemia–reperfusion Injury in Mice by Sphingosine-1-Phosphate1 Receptor Activation

Kidney International
Nephrology
2011English

The Role of Tetrahydrobiopterin and Dihydrobiopterin in Ischemia/Reperfusion Injury When Given at Reperfusion

Advances in Pharmacological Sciences
ToxicologyMolecular MedicinePharmaceuticsPharmacology
2010English

Ischemic Preconditioning Reduces the Severity of Ischemia-Reperfusion Injury of Peripheral Nerve in Rats

Journal of Brachial Plexus and Peripheral Nerve Injury
Neurology
2014English

Prevention of Renal Ischemia and Reperfusion Injury by Penehyclidine Hydrochloride Through Autophagy Activation

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy